MPS Limited completes acquisition of Unbound Medicine USA for USD 16.5 million

Listed Co AcquisitionStrategic Transactions View source PDF Explain this filing

MPSLTD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.3%Reaction day

₹1696.00

prior close

₹1690.10

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.0%+0.3% vs market

Printing & Publication peers, median of 7sector+0.0%+1.3% vs sector

On the reaction day the stock moved 0.3 pts more than Nifty Microcap 250 and 1.3 pts more than its Printing & Publication peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

+0.5

15m

+2.3

30m

+1.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.3+1.0+0.3+0.0+1.3

Next day

-0.5+0.5-0.9+0.4-0.8

-9.2-0.0-9.2-5.0-4.2

-13.1-1.5-11.7+0.2-13.4

-12.1-2.2-9.9-2.2-9.9

-3.5-1.2-2.2-3.1-0.3

-3.9-2.4-1.5-1.3-2.6

15d

-15.8-8.8-6.9-10.3-5.5

-16.3-8.3-8.0-9.8-6.4

+2.0-3.5+5.5-4.7+6.7

-2.1+6.4-8.5-2.9+0.8

UpDownMarket · Nifty Microcap 250Sector · Printing & Publication peers, median of 7Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

MPS Limited's wholly-owned subsidiary MPS North America LLC has completed the acquisition of 100 percent stake in Unbound Medicine Inc., USA for USD 16.50 million, subject to customary adjustments. The deal follows the Stock Purchase Agreement signed on 30 January 2026, with all closing conditions now met and consideration paid. Unbound Medicine has become a wholly-owned step-down subsidiary of MPS Limited from the date of completion. The move strengthens MPS's presence in the US healthcare and medical content services market.

Likely market impact

Adds a new step-down subsidiary in US healthcare content services, expanding MPS's footprint. Deal size is modest relative to company scale.